UFP Technologies, Inc.
NASDAQ:UFPTMedical - Devices
+$10.10 today
- Market cap
- $2.37B
- Beta
- 1.10
- P/E (TTM)
- 26.8
- EPS (TTM)
- $8.89
Volume 0.08M
Average 0.21M
UFPT Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
UFP Technologies, Inc.NASDAQ: UFPT
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q2 FY2026 depreciation & amortization of $4.97M rose 5.2% year over year, behind the +9.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.3% from the prior quarter. Over 3 fiscal years it compounded at +17.2% a year.
Context
- Depreciation & amortization amounted to 3.2% of revenue in FY2025, up 0.3 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +5.2% toward the trailing-twelve-month pace of +9.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 19.15M USD
- Year-over-year change
- +30.1%
- 4-year CAGR
- +22.8%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 19.15M | +30.1% |
| FY2024 | 2024-12-31 | 14.72M | +29.0% |
| FY2023 | 2023-12-31 | 11.41M | -4.0% |
| FY2022 | 2022-12-31 | 11.89M | +41.3% |
| FY2021 | 2021-12-31 | 8.41M | — |
Depreciation & Amortization vs competitors
How UFPT compares with its peers on the latest reported figures
- UFPT's LTM Jun 2026 depreciation & amortization of $19.66M is the 7th largest of the 11 companies compared; the peer median is $41M.
- Its year-over-year change of +9.0% is the 4th highest of 11, against a peer median of +4.2%.
- Depreciation & amortization amounts to 3.1% of revenue for UFPT, versus a peer median of 4.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $2.85B | -3.4% | +3.1% | 7.6% | |
| LTM Jun 2026 | $607M | +7.1% | -3.0% | 3.0% | |
| LTM Apr 2026 | $297.05M | +3.2% | +10.2% | 13.0% | |
| LTM Mar 2026 | $153.07M | +3.8% | +8.7% | 9.3% | |
| LTM Mar 2026 | $60.2M | -10.3% | +2.2% | 4.4% | |
| LTM Mar 2026 | $21.79M | +14.1% | +17.3% | 9.0% | |
| LTM Jun 2026 | $19.66M | +9.0% | +17.2% | 3.1% | |
| LTM Sep 2026 | $10.57M | +4.6% | +34.1% | 4.0% | |
| LTM Mar 2026 | $8.15M | +78.5% | -7.6% | 4.0% | |
| LTM Mar 2026 | $3.32M | +1.4% | -6.7% | 2.6% | |
| LTM Mar 2026 | $1.19M | +110.8% | +123.3% | 2.5% | |
| Peer median (excluding UFPT) | $41M | +4.2% | +5.9% | 4.2% | |
Competitors are the stored peer set for UFPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 15.89M | 41.79M | 44.92M | 58.98M | 68.31M |
| Depreciation & Amortization | 8.41M | 11.89M | 11.41M | 14.72M | 19.15M |
| Deferred Income Tax | (1.79M) | (4.71M) | 816K | 1.33M | 5.11M |
| Stock-Based Compensation | 2.43M | 3.21M | 4.64M | 6.84M | 8.85M |
| Change in Working Capital | (10.62M) | (22.47M) | (24.13M) | (16.34M) | (9.7M) |
| Accounts Receivables | (6.86M) | (15.91M) | (12.11M) | (2.19M) | 4.79M |
| Inventory | (4.5M) | (19.61M) | (16.57M) | (4.69M) | 3.9M |
| Accounts Payables | 102K | 9.13M | 1.55M | (1.14M) | (1.09M) |
| Other Working Capital | 632K | 3.92M | 2.99M | (8.32M) | (17.3M) |
| Other Non-Cash Items | (14K) | (11.96M) | 3.67M | 1.06M | 180K |
| Operating Cash Flow | 14.29M | 17.74M | 41.33M | 66.59M | 91.91M |
| Capital Expenditures | (5.4M) | (13.78M) | (10.49M) | (9.66M) | (12.93M) |
| Acquisitions (Net) | (96.18M) | (20.65M) | 0 | (197.48M) | (14.72M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 114K | 35.72M | 2K | (3.03M) | 51K |
| Investing Cash Flow | (101.46M) | 1.29M | (10.49M) | (210.16M) | (27.6M) |
| Debt Repayment | 74.81M | (20M) | (23M) | 157.3M | (53.92M) |
| Common Stock Issued | 0 | 0 | 680K | (4.72M) | 194K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (761K) | (5.83M) | (7.7M) | (188K) | (4.43M) |
| Financing Cash Flow | 74.05M | (25.89M) | (30.02M) | 152.39M | (58.16M) |
| Effect of Forex Changes | 0 | 193K | (10K) | (635K) | 699K |
| Net Change in Cash | (13.12M) | (6.67M) | 812K | 8.19M | 6.85M |
| Free Cash Flow | 8.9M | 3.96M | 30.84M | 56.94M | 78.98M |
UFP Technologies, Inc.
NASDAQ:UFPT
Intrinsic Alpha fair value
Locked
Current Price
$305.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.